logo

For the Inventor, By the Inventor

Hoofddorp, Netherlands

Ferring B.v.


USPTO Granted Patents = 209

% Expired Patents = 19.6



Trademarks = 59

Forward Citations = 1,555

Loading Chart...
Loading Chart...

248 inventors (with patents filed for the assignee):

goldMedal Anders Nilsson (16 out of 49 patents)

silverMedal Kazimierz Wisniewski (14 out of 15 patents)

bronzeMedal Joan-Carles Arce (11 out of 12 patents)

4.  Daniel Plaksin (10 out of 17 patents)

5.  Ian Cottingham (9 out of 15 patents)

6.  Egbert A Van Der Meulen (9 out of 9 patents)

7.  Guangcheng Jiang (9 out of 26 patents)

8.  Keith A Moore (9 out of 15 patents)

9.  Ralph A Heasley (9 out of 9 patents)

10.  Jeffrey S Greiwe (9 out of 9 patents)

11.  John W Facemire (9 out of 9 patents)

12.  Jason D Modest (9 out of 9 patents)

13.  Bjarke Mirner Klein (8 out of 8 patents)

14.  Hans Lindner (8 out of 9 patents)

15.  Jukka Tuominen (8 out of 8 patents)


Core Competencies:
Corticosteroids
GnRH Antagonist
Controlled Ovarian Stimulation
Recombinant FSH
Bacteriophage Therapy
Liquid Formulations
BMP-2 Amplifier
Desmopressin
Ovarian Stimulation
Vasopressin-2 Receptor
Topical Composition
Fast Dissolving

209 patents:

1. 12697372 - Composition comprising HP-hMG for use in treating infertility (2026-08-04),
2. 12653864 - Recombinant FSH composition for controlled ovarian stimulation (2026-06-16),
3. 12539306 - Mucoadhesive pharmaceutical compositions of corticosteroids (2026-02-03),
4. 12533387 - Methods of treating prostate cancer with GnRH antagonist (2026-01-27),
5. 12514898 - Methods of treating prostate cancer with GnRH antagonist (2026-01-06),
6. 12478660 - HUMAN-DERIVED RECOMBINANT FSH FOR CONTROLLED OVARIAN (2025-11-25),
7. 12458634 - Stabilized liquid formations containing picosulfate (2025-11-04),
8. 12447196 - Stable liquid gonadotropin formulation (2025-10-21),
9. 12311012 - Compositions and methods for controlled ovarian stimulation (2025-05-27),
10. 12303850 - Miniaturised device for automated manufacture of pharmaceutical compositions, and associated method (2025-05-20),
11. 12234272 - Pharmaceutical preparation comprising recombinant HCG (2025-02-25),
12. 12173040 - Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis (2024-12-24),
13. 12139558 - Method of manufacturing a pharmaceutical composition (2024-11-12),
14. 12016955 - Pharmaceutical formulations (2024-06-25),
15. 11963995 - Methods comprising desmopressin (2024-04-23),
FERRING B.V. is a global biopharmaceutical company specializing in research, development, and commercialization of innovative treatments in the fields of reproductive health, urology, gastroenterology, endocrinology, and orthopedics. With a focus on improving the quality of life for patients worldwide, FERRING B.V. utilizes cutting-edge science and collaborations to bring effective and safe medications to market.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Ferring B.v.
209 Patents

#2 in Hoofddorp

#39 in Netherlands

#4,067 in the World

Hoofddorp, NL
Hoofddorp, Netherlands

Ferring B.v.

Forward Citations = 1,555

248 inventors:

goldMedal Anders Nilsson (16 out of 49 patents)

silverMedal Kazimierz Wisniewski (14 out of 15 patents)

bronzeMedal Joan-Carles Arce (11 out of 12 patents)

4.  Daniel Plaksin (10 out of 17 patents)

5.  Ian Cottingham (9 out of 15 patents)

Please report any incorrect information to [email protected]
Loading…